drug interaction(s) of aldosterone antagonists with SGLT2-inhibitor
Jump to navigation
Jump to search
Drug interactions
- little influence of aldosterone antagonists spironolactone or eplerenone on SGLT2-inhibitor empagliflozin benefits for patients with left ventricular systolic dysfunction[1]
More general terms
References
- ↑ 1.0 1.1 Ferreira JP et al. Interplay of mineralocorticoid receptor antagonists and empagliflozin in heart failure: EMPEROR-Reduced. J Am Coll Cardiol 2021 Mar 23; 77:1397 PMID: https://www.ncbi.nlm.nih.gov/pubmed/33736821 Free article https://www.sciencedirect.com/science/article/pii/S0735109721002394